« Back to Record
De Greve, J., Van Meerbeeck, J., Vansteenkiste, J., Teugels, E., Geers, C., Meert, A.-P., Vuylsteke, P., Focan, C., Canon, J.-L., Humblet, Y., Berchem, G., Colinet, B., Galdermans, D., & Bosquée, L. (2011). First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicentre academic phase II study in caucasian patients (pts) (NCT00339586). Journal of clinical oncology.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/112532



